Biomarkers · Chemical
eGFR Creat-Cyst C
- Primary unit
- mL/min/1.73
- LOINC codes
- 50210-4, 98980-6
- Tests that measure eGFR Creat-Cyst C
- Quest Diagnostics 5, Labcorp 3
Ranges
Compare the reference ranges labs publish with guideline targets, diagnostic cut-offs, study-based ranges and practitioner targets. Move across the rows to check a value against each range, and open a source from the legend. How to read these ranges
eGFR Creat-Cyst C, mL/min/1.73 m2
- Lab reference ranges2 labs
- Diagnostic cut-offs7 cut-offs
All 9 published ranges, with sources
Lab reference ranges
Quest, adults60 mL/min/1.73 m2 and above
Adults
Printed with the creatinine result as 60 mL/min/1.73m2 or higher.
Labcorp, adults60 mL/min/1.73 m2 and above
Adults
Published as above 59 mL/minute/1.73 m2.
Labcorp test menu, Glomerular Filtration Rate, Estimated (eGFR) (100768), 2026
Diagnostic cut-offs
KDIGO 2024 CKD criterionbelow 60 mL/min/1.73 m2
Adults
GFR below 60 mL/min/1.73 m2 for at least 3 months is one of two criteria for CKD; ACR of 30 mg/g or more is the other.
KDIGO 2024 category G190 mL/min/1.73 m2 and above
Adults
Normal or high: 90 or above.
KDIGO 2024 category G260 to 89 mL/min/1.73 m2
Adults
Mildly decreased: 60 to 89.
KDIGO 2024 category G3a45 to 59 mL/min/1.73 m2
Adults
Mildly to moderately decreased: 45 to 59.
KDIGO 2024 category G3b30 to 44 mL/min/1.73 m2
Adults
Moderately to severely decreased: 30 to 44.
KDIGO 2024 category G415 to 29 mL/min/1.73 m2
Adults
Severely decreased: 15 to 29.
KDIGO 2024 category G5below 15 mL/min/1.73 m2
Adults
Kidney failure: below 15.
Tests
Check the catalog code, specimen, method and preparation for every test that measures eGFR Creat-Cyst C. Select up to five tests to compare them side by side.
Quest Diagnostics 5 tests
Panels that include this biomarker
Cystatin C with Glomerular Filtration Rate, Estimated (eGFR) 94588
2 analytes · Serum · Fasting not stated
Quest Diagnostics catalog pageMethod and collection
- Method
- Particle Enhanced Turbidimetric Immunoassay (PETIA)
- Reference notes
- See Laboratory Report
LUNGSEQ Panel 36915
10 analytes · Tissue · Fasting not stated · Turnaround Set up: Mon, Wed
Quest Diagnostics catalog pageMethod and collection
- Method
- Next Generation Sequencing
- Collection
- Specimen to be tested must contain a minimum of 10% tumor
- Reference notes
- See Laboratory Report
COLONSEQPlus Panel 36919
14 analytes · Tissue · Fasting not stated · Turnaround Set up: Tues
Quest Diagnostics catalog pageMethod and collection
- Method
- Next Generation Sequencing • Polymerase Chain Reaction (PCR) • MSI
- Collection
- Specimen to be tested must contain a minimum of 10% tumor
- Reference notes
- See Laboratory Report
Solid Tumor Core Panel 93234
47 analytes · Tissue · Fasting not stated
Quest Diagnostics catalog pageMethod and collection
- Method
- Next Generation Sequencing
- Collection
- For FFPE and slides a pathology report must be submitted with sample. Do not reject.
- Reference notes
- See Laboratory Report
Comprehensive Hereditary Cancer Panel 38600
65 analytes · Blood · Fasting not stated
Quest Diagnostics catalog pageMethod and collection
- Method
- DNA Bait Capture • Long Range Polymerase Chain Reaction • Next Generation Sequencing • Microarray
- Preparation
- Saliva: Do not eat, drink, smoke or chew gum for 30 minutes before collection. Buccal swab: Please refer to user instructions provided with kit. Ensure the sponge tip does not come into contact with any surface prior to collection. Do not eat, drink, smoke, or chew gum for 30 minutes before collection. Do not touch swab tips or allow contact with any other object.
- Collection
- Do not hold specimen. Forward to laboratory when specimen arrives. Whole blood: Normal phlebotomy procedure. Specimen stability is crucial. Store and ship room temperature immediately. Do not freeze. Saliva: 2 mL saliva collected in the Oragene-Dx collection kit up to the "fill to" line (OGD-500/OGD-600, OGD-510/OGD-610). Do not remove the plastic film from the funnel lid. For fibroblasts and skin fibroblasts, call 1-866-GENEINFO (1-866-436-3463) prior to collecting and ordering.
- Reference notes
- See Laboratory Report
Labcorp 3 tests
Panels that include this biomarker
Cystatin C With Glomerular Filtration Rate, Estimated (eGFR) 121265
2 analytes · Serum · Fasting not stated · Turnaround 2 - 5 days
Labcorp catalog pageMethod and collection
- Method
- Turbidimetric (directly traceable to ERM-DA471/IFCC, the international standard reference material)
- Preparation
- Overnight fasting is preferred.
- Collection
- If green-top (heparin) tube is used, separate plasma from red blood cells and transfer plasma to a transfer tube.
eGFR Creatinine-Cystatin C Calculation 121022
3 analytes · Serum · Fasting not stated · Turnaround 2 - 5 days
Labcorp catalog pageMethod and collection
- Method
- Creatinine: Kinetic Jaffe Cystatin C: Turbidimetric (directly traceable to ERM-DA471/IFCC, the international standard reference material)
- Collection
- If green-top (heparin) tube is used, separate plasma from red blood cells and transfer plasma to a transfer tube.
eGFR Creatinine-Cystatin C Calculation With Albumin:Creatinine Ratio, Urine 121054
6 analytes · Serum · Fasting not stated · Turnaround 2 - 5 days
Labcorp catalog pageMethod and collection
- Method
- Creatinine: Kinetic Jaffe Cystatin C: Turbidimetric (directly traceable to ERM-DA471/IFCC, the international standard reference material) Albumin: Immunoturbidimetric
- Collection
- If green-top (heparin) tube is used, separate plasma from red blood cells and transfer plasma to a transfer tube. Collect random urine without preservatives. pH must be 4-8.
0 of 5 tests selected
Pick one moreGoals and conditions
We link eGFR Creat-Cyst C to these goals and conditions from named guidelines and studies.
Kidney functionGoal, primary marker
KDIGO stages kidney function into GFR categories G1 to G5.
Chronic kidney diseaseCondition, ICD-10 N18.9, primary marker
KDIGO counts GFR below 60 mL/min/1.73 m2 for 3 months or more as one CKD criterion.
Type 2 diabetesCondition, ICD-10 E11.9, companion marker
ADA assesses eGFR at least annually in all people with type 2 diabetes.
Sources
3 tests: codes, specimens, methods, preparation and reference intervals.
Quest Diagnostics test catalog
5 tests: codes, specimens, methods, preparation and reference intervals.
Clinical guideline: Type 2 diabetes (companion)
Clinical guideline: Chronic kidney disease (primary), Kidney function (primary), Range: KDIGO 2024 CKD criterion, Range: KDIGO 2024 category G1, Range: KDIGO 2024 category G2, Range: KDIGO 2024 category G3a, Range: KDIGO 2024 category G3b, Range: KDIGO 2024 category G4, Range: KDIGO 2024 category G5
Labcorp test menu, Glomerular Filtration Rate, Estimated (eGFR) (100768), 2026
Laboratory catalog: Range: Labcorp, adults
Quest Diagnostics Test Directory, Creatinine (375), 2025
Laboratory catalog: Range: Quest, adults
Regenstrief Institute codes that identify the same result across labs.
Search ClinicalTrials.gov for eGFR Creat-Cyst C
Registered studies that measure eGFR Creat-Cyst C, on the U.S. National Library of Medicine registry.
Verify these ranges and sources
We compile this page from named laboratory catalogs, guidelines and studies. Labs calculate reference intervals from the people they test, for one assay method and one population group, so an interval describes that population rather than an optimal target.
Interpret your own results with a licensed clinician, or track your lab history and health goals in Aumnivida.
Spotted an error? Email hello@biomarkerlens.com with the page URL and the primary source that corrects the entry.